Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Solventum (SOLV) Research & Development (2023 - 2025)

Solventum's Research & Development history spans 3 years, with the latest figure at $175.0 million for Q4 2025.

  • For Q4 2025, Research & Development fell 12.06% year-over-year to $175.0 million; the TTM value through Dec 2025 reached $740.0 million, down 4.52%, while the annual FY2025 figure was $739.0 million, 4.65% down from the prior year.
  • Research & Development reached $175.0 million in Q4 2025 per SOLV's latest filing, down from $183.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $199.0 million in Q4 2024 to a low of $175.0 million in Q4 2025.
  • Average Research & Development over 3 years is $189.4 million, with a median of $191.0 million recorded in 2023.
  • Peak YoY movement for Research & Development: grew 5.0% in 2024, then fell 12.06% in 2025.
  • A 3-year view of Research & Development shows it stood at $190.0 million in 2023, then grew by 4.74% to $199.0 million in 2024, then dropped by 12.06% to $175.0 million in 2025.
  • Per Business Quant, the three most recent readings for SOLV's Research & Development are $175.0 million (Q4 2025), $183.0 million (Q3 2025), and $189.0 million (Q2 2025).